![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Green Lights Medtronic’s MRI-Conditional Cardiac Resynchronization Therapy Defibrillators
FDA Green Lights Medtronic’s MRI-Conditional Cardiac Resynchronization Therapy Defibrillators
![](https://www.fdanews.com/ext/resources/test/Device_Images2/Medtronic.gif?t=1433970926&width=430)
Medtronic was blessed with FDA approval for the first and only magnetic resonance imaging conditional cardiac resynchronization therapy defibrillators, the company announced.
The Amplia MRI Quad CRT-D SureScan and Compia MRI Quad CRT-D SureScan systems are approved for MRI scans on any part of the body without positioning restrictions.
U.S. patients who receive these devices — which help treat their heart failure and reduce their risk of sudden cardiac arrest — now will have access to MRI scans if and when they need them. Both CRT-D systems will be commercially available in the coming months. — Jonathon Shacat
Upcoming Events
-
11Jul
-
18Jul
-
21Oct